|
2,987
|
| 27206 |
CEL-c.1686delT
|
|
increases_activity of
|
MODY, type VIII
|
in CEL-c.1686delT carriers
|
| 27207 |
CEL-c.1686delT
|
|
increases_activity of
|
pancreas lipomatosis
|
in CEL-c.1686delT carriers
|
| 27208 |
CEL-c.1686delT
|
|
increases_activity of
|
exocrine pancreatic insufficiency
|
in CEL-c.1686delT carriers
|
| 27223 |
CEL-c.1686delT
|
|
increases_activity of
|
endoplasmic reticulum unfolded protein response
|
in CEL-c.1686delT carriers
|
|
21784842
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
2,990
|
| 27227 |
CEL
|
|
affects_activity of
|
impaired glucose tolerance
|
in female mice after high-fat diet
|
|
20720448
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
5,548
|
| 53527 |
CEL-c.1686delT
|
|
increases_activity of
|
MODY, type VIII
|
in CEL 1686delT mutation carriers
|
| 53529 |
CEL-c.1686delT
|
|
increases_activity of
|
Diabetes mellitus, type II
|
in CEL 1686delT mutation carriers
|
| 53531 |
CEL-c.1686delT
|
|
increases_activity of
|
exocrine pancreatic insufficiency
|
in CEL 1686delT mutation carriers
|
| 53534 |
CEL-c.1686delT
|
|
increases_activity of
|
abnormal pancreatic beta cell physiology
|
in CEL 1686delT mutation carriers
|
| 53543 |
CEL rs193922638
|
|
increases_activity of
|
MODY, type VIII
|
in CEL 1785delC mutation carriers
|
| 53546 |
CEL rs193922638
|
|
increases_activity of
|
exocrine pancreatic insufficiency
|
in CEL 1785delC mutation carriers
|
|
16369531
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
5,549
|
| 53554 |
MODY, type VIII
|
|
increases_activity of
|
abnormal pancreatic acinar cell physiology
|
|
|
23770712
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
5,550
|
| 53550 |
MODY, type VIII
|
|
increases_activity of
|
pancreas cysts
|
|
| 53596 |
MODY, type VIII
|
|
decreases_quantity of
|
CEL
|
in duodenal fluid
|
|
24062244
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
5,573
|
| 53631 |
CEL
|
|
increases_activity of
|
lipid digestion
|
in duodenum
|
| 53632 |
Bile salt
|
|
increases_activity of
|
CEL
|
in duodenum
|
|
11514232
|
Diabetes mellitus, type II
Insulin resistance
MODY, type VIII
|
|
13,933
|
| 131655 |
CEL-p.A24V
|
|
increases_activity of
|
MODY, type VIII
|
|
| 131656 |
CEL-p.D102A
|
|
increases_activity of
|
MODY, type VIII
|
|
| 131657 |
CEL-p.V161M
|
|
increases_activity of
|
MODY, type VIII
|
|
| 131658 |
CEL-p.K266E
|
|
increases_activity of
|
MODY, type VIII
|
|
| 131659 |
CEL-p.P718T
|
|
increases_activity of
|
MODY, type VIII
|
|
|
31595705
|
MODY
|
|
13,970
|
| 132017 |
CEL-p.I488T
|
|
increases_activity of
|
MODY, type VIII
|
|
|
33072637
|
MODY, type VIII
|
|
13,971
|
| 132063 |
CEL
|
|
affects_activity of
|
lipid metabolic process
|
in blood, in testis, in adrenal gland, in endothelial cells, in eosinophils, in macrophages, in pituitary gland, in liver
|
| 132072 |
MODY, type VIII
|
|
decreases_activity of
|
pancreatic acinar cell
|
|
| 132074 |
MODY, type VIII
|
|
decreases_activity of
|
pancreatic beta cell
|
|
| 132087 |
CEL
|
|
affects_activity of
|
Pancreatic adenocarcinoma
|
|
| 132088 |
CEL
|
|
affects_activity of
|
Pancreatitis, chronic
|
|
|
29552330
|
MODY, type VIII
|
CIDeRplus